Posted by Michael Wonder on 04 Feb 2019
Optum to cover Amgen, Eli Lilly migraine drugs, exclude Teva
1 February 2019 - Optum, a top U.S. pharmacy benefit manager owned by UnitedHealth Group, has included new migraine drugs from Amgen and Eli Lilly as preferred treatments on its lists of covered drugs, according to an Optum client note viewed by Reuters.
Teva Pharmaceutical Industries's rival product is excluded on one list and patients can pay more for it some cases on a second list, the note said.
Like at rivals Express Scripts and CVS Health, Optum’s lists of covered drugs, or formularies, cover tens of millions of consumers who receive their healthcare from employers and health insurers.
